Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05411354 · ClinicalTrials.gov registry record
Analyzing Clinical Trial Experiences of Prostate Cancer Patients
A clinical trial, sponsored by Power Life Sciences.
- Not yet
- Registry status
- 400
- Enrollment target
NCT05411354: Clinical Trial study, sponsored by Power Life Sciences.
NCT05411354 is a clinical trial that has not yet begun recruiting, run by Power Life Sciences. The registered enrollment target is 400 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05411354 has not yet begun recruiting, sponsored by Power Life Sciences.
- NOT YET RECRUITING
- Registry status
- 400 participants
- Enrollment target
Study Summary
Participation in clinical trials usually favors a particular demographic group. But there is limited research available to explain what trial attributes affect the participation or completion of these specific demographic groups. This study will admit a wide range of data on the clinical trial experience of Prostate Cancer patients to determine which factors prevail in limiting a patient's ability to join or finish a trial. It will also try to analyze data from the perspective of different demographic groups to check for recurring trends which might shed insights for the sake of future Prostate Cancer patients.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 400 participants |
| Start Date | 2024-09 |
| Est. Completion | 2026-09 |
What is known before NCT05411354 opens enrollment
NCT05411354 is an observational study that tracks outcomes without assigning an intervention. The registered 400 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT05411354 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05411354 about?
NCT05411354 is a clinical study titled "Analyzing Clinical Trial Experiences of Prostate Cancer Patients". Participation in clinical trials usually favors a particular demographic group. But there is limited research available to explain what trial attributes affect the participation or completion of these specific demographic groups. This study will admit a wide range of data on the clinical trial expe...
What is the current status of trial NCT05411354?
This trial is currently not yet recruiting. The enrollment target is 400 participants. The study started on 2024-09. Estimated completion is 2026-09.
Who is sponsoring clinical trial NCT05411354?
This trial is sponsored by Power Life Sciences, which has 62 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01665326 · 400 participants
Determination of CRIM Status and Longitudinal Follow-up of Individuals With Pompe Disease
- NCT02108054 · 400 participants · NA
Behavioral and Functional Task Development, Implementation, and Testing
- NCT02216500 · 400 participants · NA
Ketogenic Therapy Effects on Electrical and Metabolic Abnormalities in Epilepsy
- NCT02250352 · 400 participants
Core Biopsies for Establishing a Breast Tumor Tissue Repository
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia